EcoDrugPlus

Trace Amine Associated Receptor 1

Ensembl ID : ENSLBEG00000012925
Gene Symbol: TAAR1
1 Cross references
389 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSLBEG00000018958
Gene Symbol: TAAR1
4 Cross references
346 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSLBEG00000000429
Gene Symbol: TAAR1
1 Cross references
346 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSLBEG00000027381
Gene Symbol: TAAR1
1 Cross references
335 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSLBEG00000000503
Gene Symbol: TAAR1
1 Cross references
346 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSLBEG00000000508
Gene Symbol: TAAR1
3 Cross references
346 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSLBEG00000017522
Gene Symbol: TAAR1
1 Cross references
346 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSLBEG00000000530
Gene Symbol: TAAR1
3 Cross references
346 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSLBEG00000024843
Gene Symbol: TAAR1
4 Cross references
346 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSLBEG00000024854
Gene Symbol: TAAR1
3 Cross references
346 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSLBEG00000025029
Gene Symbol: TAAR1
3 Cross references
346 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSLBEG00000025015
Gene Symbol: TAAR1
1 Cross references
346 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).